AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 62 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $82,000 | -3.5% | 15,800 | 0.0% | 0.00% | – |
| Q4 2020 | $85,000 | +10.4% | 15,800 | 0.0% | 0.00% | – |
| Q3 2020 | $77,000 | 0.0% | 15,800 | 0.0% | 0.00% | – |
| Q2 2020 | $77,000 | -96.5% | 15,800 | -95.0% | 0.00% | -100.0% |
| Q1 2019 | $2,187,000 | -46.7% | 316,464 | -51.4% | 0.00% | -66.7% |
| Q4 2018 | $4,103,000 | -71.4% | 651,215 | -20.4% | 0.00% | -66.7% |
| Q3 2018 | $14,323,000 | – | 817,992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |